TD SYNNEX (SNX) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
8 Jan, 2026Executive summary
Achieved record Q4 and FY results with non-GAAP gross billings up 15% YoY to $24.3B, non-GAAP diluted EPS up 24% YoY to $3.83, and robust free cash flow of $1.4B, surpassing guidance and prior records.
Growth was broad-based across all regions and segments, with Asia-Pacific and Japan leading, and strong performance in Europe and Latin America.
Hyve delivered double-digit gross billings growth, exceeding expectations and diversifying its customer base.
Disciplined capital allocation supported strong shareholder returns, with $742M returned in FY25 via dividends and share repurchases.
Quarterly dividend raised 9% to $0.48 per share, payable January 30, 2026.
Financial highlights
Q4 gross billings up 15% YoY to $24.3B; net revenue $17.4B, up 10% YoY and above guidance.
Gross profit increased 15% YoY to $1.2B; gross margin as a percentage of gross billings was 5% (flat YoY), while reported gross margin improved to 6.9%.
Non-GAAP operating income up 18% YoY to $497M; GAAP operating income $399M, up 23%.
Non-GAAP net income $313M; non-GAAP diluted EPS $3.83, up 24% YoY; GAAP diluted EPS $3.04, up 33%.
Free cash flow for the year was $1.4B, exceeding expectations.
Outlook and guidance
Q1 FY26 non-GAAP gross billings expected at $22.7–$23.7B; net revenue guidance: $15.1–$15.9B.
Non-GAAP net income forecasted at $243M–$283M; non-GAAP diluted EPS: $3.00–$3.50.
Quarterly dividend of $0.48 per share declared, payable January 30, 2026.
Anticipates Q1 cash outflow due to seasonality and timing; expects cumulative free cash flow for FY25–26 to align with 95% net income conversion.
Long-term outlook remains consistent with multi-year growth targets.
Latest events from TD SYNNEX
- Key votes include director elections, say-on-pay, auditor ratification, and a charter amendment.SNX
Proxy Filing13 Feb 2026 - Proxy covers director elections, say-on-pay, auditor ratification, and ESG progress.SNX
Proxy Filing13 Feb 2026 - Board seeks approval for director elections, executive pay, auditor ratification, and expanded shareholder rights.SNX
Proxy Filing3 Feb 2026 - Q2 delivered 3% gross billings growth, margin gains, and strong shareholder returns.SNX
Q2 20243 Feb 2026 - Q3 non-GAAP gross billings up 9% to $20.3B; revenue $14.7B; Q4 outlook strong.SNX
Q3 202420 Jan 2026 - Q4 revenue rose 10% with strong cash flow, robust capital returns, and a higher dividend.SNX
Q4 202410 Jan 2026 - Gross billings up 8%, revenue up 4%, EPS within guidance, and dividend raised 10%.SNX
Q1 202520 Dec 2025 - Board recommends FOR all management proposals and AGAINST lowering the special meeting threshold.SNX
Proxy Filing1 Dec 2025 - Proxy covers director elections, governance reforms, and strong financial and ESG performance.SNX
Proxy Filing1 Dec 2025